Both in Pharmaceuticals
uniQure vs Ultragenyx Pharmaceutical
Over the past year QURE returned −33.1% and RARE returned −47.7%; their daily moves had a correlation of 0.12.
QURE −33.1% RARE −47.7%Growth of $1, one year, split-adjusted
| Metric | QURE | RARE |
|---|---|---|
| Price | $22.93 | $17.49 |
| Market cap | $1.59B | $1.72B |
| Today | −3.94% | +5.17% |
| 1 month | −0.6% | +21.0% |
| 6 months | +0.5% | −32.5% |
| Year to date | −4.2% | −24.0% |
| 1 year | −33.1% | −47.7% |
| Revenue growth (YoY) | +11.0% | +28.1% |
| Gross margin | 94.0% | 84.1% |
| Net margin | −1387.8% | −43.0% |
| P/E (TTM) | — | — |
| Price / sales | 85.2× | 2.4× |
| Net cash | $760.2M | $292.0M |
| Dividend yield | — | — |
| Volatility (60d) | 109.2% | 128.8% |
| Short % of float | 13.2% | 21.5% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).